CRISPR/Cas9 Optimization Using Electronic Genome Mapping: Potential Role for Studying Human Genetic Disease

Gain deeper insights and drive breakthroughs in hematological malignancy research with the OhmX™ Platform,  powered by electronic genome mapping (EGM) and expertly engineered to unravel the complexities of structural variants (SVs) in cancer genomes.

Gain confidence in your genomic discoveries from NGS and long-read sequencing (LRS) platforms with a low-cost solution to verify, clarify, and identify structural variant (SV) calls.

Unravel complexities and gain critical insights with the OhmX™ Platform, designed to help you push the boundaries of rare disease research.

Detect and confirm complex repeat expansions with the OhmX™ Platform, delivering accurate sizing and structural insight beyond the limits of PCR and traditional sequencing methods.